Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

The Effect of Mental Fatigue on Upper Extremity Functional Performance

NCT07645404 · tracked via the Priya Life Science Belgium tracker
Phase
Not applicable
Started
2026-07-01
Last updated
2026-06-15

Condition(s) studied

Mental Fatigue

Investigational drug(s) / intervention(s)

Mental Fatigue

Mental Fatigue: Mental fatigue (MF) is a psychobiological state characterized by feelings of tiredness and/or a measurable decline in performance following prolonged or intense cognitive activity.

Study summary

Mental fatigue (MF) is known to impair cognitive performance and may negatively affect physical performance. While its effects on lower-extremity functional performance have been investigated, little is known about the influence of MF on upper-extremity physical performance tests commonly used in sports and rehabilitation settings. This randomized crossover study will investigate the effects of experimentally induced mental fatigue on upper-extremity physical performance in 16 healthy physically active adults. Participants will complete both a mental fatigue condition, involving a prolonged Stroop task, and a control condition consisting of watching an emotionally neutral documentary. Before and after each condition, participants will perform the Upper Quarter Y Balance Test, Reactive Upper Quarter Y Balance Test, Closed Kinetic Chain Upper Extremity Stability Test, and Seated Single-Arm Shot Put Test. Subjective mental fatigue, cognitive performance, motivation, and perceived exertion will also be assessed. The findings will improve understanding of whether mental fatigue influences upper-extremity physical performance test outcomes and may assist clinicians and researchers in interpreting these assessments in sports medicine and rehabilitation contexts.

Eligibility

Sex
ALL
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age between 18 and 35 years * Healthy (no neurological, cardiovascular or musculoskeletal disorders of any kind) * Male or female * No prior knowledge of the concept of mental fatigue * Not currently taking medications that affect cognition or neuromuscular performance * According to the International Physical Activity Questionnaire, being physically active at a minimum level of 1500 MET-min/week Exclusion Criteria: * Previous major upper limb injury (last 6 months) * Involvement in another concurrent physical or cognitive intervention study * Use of caffeine and heavy efforts 24 hours prior each trial * Suffering from colour vision deficiencies * Not eating a standardized meal, the morning of each trial and the evening before each trial

Primary outcome measure(s)

  • Reactive Upper Quarter Y Balance Test — Pre-intervention and immediately post-intervention (each experimental and control condition session)
    Measures visuomotor reaction time, reaching accuracy, and balance errors during a reactive upper quarter Y balance test performed under visual stimuli conditions.
  • Closed Kinetic Chain Upper Extremity Stability Test — Pre-intervention and immediately post-intervention (each session)
    Assesses upper-extremity muscular endurance and stability by counting the number of alternating hand touches performed in a 15-second push-up position task.
  • Upper Quarter Y Balance Test — Pre-intervention and immediately post-intervention (each session)
    Evaluates dynamic upper-extremity reach performance and composite score based on normalized reach distances in three directions.
  • Seated Single-Arm Shot Put Test — Pre-intervention and immediately post-intervention (each session)
    Measures upper-extremity explosive power based on throwing distance of a 6-lb medicine ball.

Trial sites (1)

FacilityCityRegionStatus
Vrije Universiteit Brussel Brussels Pleinlaan 2

More Izmir Bakircay University trials in Belgium

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07645404 on ClinicalTrials.gov ↗ ← All trials in Belgium